User profiles for Ross T. Tsuyuki
Ross TsuyukiProfessor, University of Alberta Verified email at ualberta.ca Cited by 28330 |
Acute precipitants of congestive heart failure exacerbations
RT Tsuyuki, RS McKelvie, JMO Arnold… - Archives of internal …, 2001 - jamanetwork.com
Background Few studies have prospectively and systematically explored the factors that
acutely precipitate exacerbation of congestive heart failure (CHF) in patients with left ventricular …
acutely precipitate exacerbation of congestive heart failure (CHF) in patients with left ventricular …
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: diagnosis and management
…, EJ Sequeira, AM Svendsen, K Teo, RT Tsuyuki… - Canadian Journal of …, 2006 - Elsevier
Heart failure remains a common diagnosis, especially in older individuals. It continues to be
associated with significant morbidity and mortality, but major advances in both diagnosis …
associated with significant morbidity and mortality, but major advances in both diagnosis …
A meta-analysis of the association between adherence to drug therapy and mortality
Objective To evaluate the relation between adherence to drug therapy, including placebo,
and mortality. Design Meta-analysis of observational studies. Data sources Electronic …
and mortality. Design Meta-analysis of observational studies. Data sources Electronic …
Validity and reliability of the Edmonton Frail Scale
DB Rolfson, SR Majumdar, RT Tsuyuki, A Tahir… - Age and …, 2006 - academic.oup.com
Methods Our objective was to assess the validity and reliability of the Edmonton Frail Scale (EFS)
in a sample referred for CGA (Table 1). All patients aged 65+ years were approached …
in a sample referred for CGA (Table 1). All patients aged 65+ years were approached …
Hypertension Canada's 2018 guidelines for diagnosis, risk assessment, prevention, and treatment of hypertension in adults and children
…, RD Feldman, KL Lavoie, RT Tsuyuki… - Canadian Journal of …, 2018 - Elsevier
Hypertension Canada provides annually updated, evidence-based guidelines for the diagnosis,
assessment, prevention, and treatment of hypertension in adults and children. This year, …
assessment, prevention, and treatment of hypertension in adults and children. This year, …
A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists …
RT Tsuyuki, JA Johnson, KK Teo… - Archives of internal …, 2002 - jamanetwork.com
Background Despite clear evidence for the efficacy of lowering cholesterol levels, there is a
deficiency in its real-world application. There is a need to explore alternative strategies to …
deficiency in its real-world application. There is a need to explore alternative strategies to …
Why do patients with atrial fibrillation not receive warfarin?
…, KK Teo, FA McAlister, RT Tsuyuki - Archives of internal …, 2000 - jamanetwork.com
Atrial fibrillation (AF) is a growing public health problem associated with significant morbidity
and mortality. Numerous randomized controlled trials of warfarin have conclusively …
and mortality. Numerous randomized controlled trials of warfarin have conclusively …
Randomized trial of the effect of pharmacist prescribing on improving blood pressure in the community: the Alberta clinical trial in optimizing hypertension (RxACTION)
Background— Hypertension control rates remain suboptimal. Pharmacists’ scope of practice
is evolving, and their position in the community may be ideal for improving hypertension …
is evolving, and their position in the community may be ideal for improving hypertension …
The effectiveness of pharmacist interventions on cardiovascular risk: the multicenter randomized controlled RxEACH trial
Background : Despite the cardiovascular disease (CVD) risk associated with hypertension,
diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and controlled…
diabetes, dyslipidemia, and smoking, these risk factors remain poorly identified and controlled…
Improved clinical outcomes associated with metformin in patients with diabetes and heart failure
…, SR Majumdar, FA McAlister, RT Tsuyuki… - Diabetes …, 2005 - Am Diabetes Assoc
OBJECTIVE—Metformin is considered contraindicated in patients with heart failure because
of concerns over lactic acidosis, despite increasing evidence of potential benefit. The aim of …
of concerns over lactic acidosis, despite increasing evidence of potential benefit. The aim of …